6
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Influence of Continued Asbestos Exposure on the Outcome of Asbestosis in Sheep

, &
Pages 971-984 | Received 25 Aug 1990, Accepted 23 Nov 1990, Published online: 02 Jul 2009

References

  • Becklake M R. Asbestos related diseases of the lung and other organs: epidemiology and implications for clinical practice. Am Rev Respir Dis 1976; 114: 187–227
  • Churg A, Green F HY. Pathology of occupational lung disease. Igaku-Shoin, New York 1989
  • Craighead J E, Abraham J L, Churg A, Green F HY, Kleinerman J, Pratt P C, Seemayer T A, Vallyathan V, Weill H. The pathology of asbestos-associated diseases of the lung and pleural cavities: diagnostic criteria and proposed grading scheme. Arch Pathol Lab Invest 1982; 106: 544–595
  • Viallat J R, Boutin C. Radiologic changes in chrysotile mine and mill ex-workers in Corsaca. Lung 1980; 157: 155–163
  • McMillan G HG, Rossiter C E, Deacon R. Comparison of independent randomized reading of radiographs with direct progression scoring for assessing change in asbestos-related pulmonary and pleural lesions. Br J Indust Med 1982; 39: 60–61
  • Selikoff I J. Disease prevention in asbestos insulation work. In Safety and Health in Shipbuilding and Repairing. International Labor Organization [ILO] publication 27 1972; 27: 13–26
  • Becklake M R, Liddell F DK, Manfreda J, McDonald J C. Radiolabeled changes after withdrawal from asbestos exposure. Br J Indust Med 1979; 36: 23–38
  • Coutts I I, Turner-Warwick M. Factors predicting outcome in the intrapulmonary fibrosis associated with asbestos exposure [asbestosis]. Occupational Lung Disease, J BL Gee, K WC Morgan, S M Brooks. Raven, New York 1984; 208–209
  • Selikoff I J, Lee D HK. Asbestos and Disease. Academic, New York 1978; 176–177
  • Hunt R. Routine lung function studies on 820 employees in an asbestos factory. Ann NY Acad Sci 1965; 132: 406–420
  • Viallat J R, Boutin C, Pietri J F, Fondarai J. Late progression of radiographic changes in Canari cyrysotile mine and mill exworkers. Arch Environ Health 1983; 38: 54–58
  • Rubino G F, Newhouse M, Murray R, Scansetti G, Piolatto G, Aresini G. Radiologic changes after cessation of exposure among chrysotile miners in Italy. Ann NY Acad Sci 1979; 330: 157–161
  • Gregor A, Parkes R W, duBois R, Turner-Warwick M. Radiologic progression of asbestosis: preliminary report. Ann NY Acad Sci 1979; 330: 147–156
  • McMillan G HG, Rossiter C E. Development of radiological and clinical evidence of parenchymal fibrosis in men with non-malignant asbestos-related pleural lesions. Br J Indust Med 1982; 39: 54–59
  • Jones R N, Glindmeyer H, Weill H, Gilson J C. Progression of asbestos radiographic abnormalities: relationship to estimates of dust exposure and annual decline in lung function. Biological effects of mineral fibres. 1980; Vol. 2: 537–543, IARC publication No. 30
  • Leatheart G L. Clinical, bronchographic, radiological and physiological observations in ten cases of asbestosis. Br J Indust Med 1960; 17: 213–225
  • Liddell F DK. Assessment of radiological progression of simple pneumoconiosis in individual miners. Br J Indust Med 1974; 31: 185–195
  • Amandus H E, Reger R B, Pendergrass E P, Dennis J M, Morgan W KC. The pneumoconioses: methods of measuring progression. Chest 1973; 63: 736–743
  • Becklake M R, Thomas D, Lidell F DK, McDonald J C. Follow-up respiratory measurements in Québec chrysotile miners and millers. Scan J Work Environ Health 1982; 8(suppl)105–110
  • Seidman H, Selikoff I J, Hammond E C. Short-term asbestos work exposure and long-term observation. Ann NY Acad Sci 1979; 330: 61–89
  • Bégin R, Cantin A, Massé S. Recent advances in the clinical assessment and pathogenesis of the mineral dust pneumoconiosis. Eur Respir J 1989; 2: 988–1001
  • Berry G. Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br J Indust Med 1981; 38: 130–137
  • Gaensler E A, Jederlinic P J, McLoud T C. Progression of asbestosis. Am Rev Respir Dis 1988; 137(4)92
  • Bégin R, Rola-Pleszczynski M, Sirois P, Massé S, Nadeau D, Bureau M A. Sequential analysis of the bronchoalveolar milieu in conscious sheep. J Appl Physiol 1981; 50: 665–671
  • Bégin R, Rola-Pleszczynski M, Sirois P, Lemaire I, Nadeau D, Bureau M A, Massé S. Early lung events following low-dose asbestos exposure. Environ Res 1981; 26: 392–401
  • Bégin R, Massé S, Bureau M A. Morphologic features and function of the airways in early asbestosis in the sheep model. Am Rev Respir Dis 1982; 126: 870–876
  • Bégin R, Rola-Pleszczynski M, Massé S, Lemaire I, Sirois P, Boctor M, Nadeau D, Drapeau G, Bureau M A. Asbestos-induced lung injury in the sheep model: the initial alveolitis. Environ Res 1983; 30: 195–210
  • Bégin R, Cantin A, Drapeau G, Lamoureux G, Boctor M, Massé S, Rola-Pleszczynski M. Pulmonary intake of Gallium-67 in asbestos exposed humans and sheep. Am Rev Respir Dis 1983; 127: 623–630
  • Bégin R, Rola-Pleszczynski M, Massé S, Nadeau D, Drapeau G. Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests. Thorax 1983; 38: 449–457
  • Lemaire I, Rola-Pleszczynski M, Bégin R. Asbestos exposure enhances the release of fibroblast growth factors by sheep alveolar macrophages. J Reticuloendothelial Soc 1983; 33: 275–285
  • Massé S, Boctor M, Bégin R. Pathological, radiological and functional correlations in early asbestosis of the sheep. ILO 6th International Pneumoconiosis Conference Monograph. 1984; Vol. 2: 961–987
  • Sébastien P, Bégin R. Alveolar clearance of chrysotile in the sheep model: preliminary observations. ILO 6th International Pneumoconiosis Conference Monograph. 1984; Vol. 2: 1010–1020
  • Bégin R, Massé S, Sébastien P, Bossé J, Rola-Pleszczynski M, Boctor M, Côté Y, Fabi D, Dalle D. Asbestos exposure and retention as determinants of airway disease and asbestos alveolitis. Am Rev Respir Dis 1986; 134: 1176–1181
  • Bégin R, Massé S, Sébastien P. Determinants of biological effects of chrysotile in the lung exposure-dose, fiber size or chemistry and individual susceptibility. Accomplishments in Oncology, Vol. 1 (2), The Biological Effects of Chrysotile, J C Wagner. Lippincott, Philadelphia 1986; 74–110
  • Bégin R, Massé S, Rola-Pleszczynski M, Drapeau G. Bronchoalveolar and lung tissue analyses in asbestos-exposed humans and sheep. In Vitro Effects of Mineral Dusts, Beck, Bignon. Springer, Heidelberg 1985; 359–367
  • Sébastien P, Bégin R, Case B W, McDonald J C. Inhalation of chrysotile dust. Accomplishments in Oncology, Vol. 1 (2), The Biological Effects of Chrysotile, J C Wagner. Lippincott, Philadelphia 1986; 19–29
  • Bégin R, Martel M, Desmarais Y, Drapeau G, Boileau R, Rola-Pleszczynski M, Massé S. Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep. Chest 1986; 89: 237–243
  • Bégin R, Cantin A, Massé S. Effects of cyclophosphamide treatment in experimental asbestosis. Exp Lung Res 1988; 14: 823–836
  • Bégin R, Sébastien P. Excessive asbestos fibre accumulation in the bronchoalveolar space may be a marker of individual susceptibility to develop asbestosis: experimental evidence. Br J Indust Med 1989; 46: 853–855
  • Bégin R, Massé S, Sébastien P. Alveolar dust clearance capacity as determinant of individual susceptibility to asbestosis: experimental observations. Ann Occup Hyg 1989; 33: 279–282
  • Bégin R, Cantin A, Sébastien P. Chrysotile exposure can produce an alveolitis with limited fibrosing activity in a subset of susceptible sheep. Eur Respir 1990; 3: 81–90
  • Sébastien P, Bégin R. Mass, number and size of fibres in the pathogenesis of asbestosis in sheep. Br J Exp Pathol 1990; 71: 1–10
  • Bégin R, Cantin A, Berthiaume Y, Boileau R, Bisson G, Lamoureux G, Rola-Pleszczynski M, Drapeau G, Massé S, Boctor M, Breault J, Péloquin S, Dalle D. Clinical features to stage alveolitis in asbestos workers. Am J Indust Med 1985; 8: 521–536
  • Rom W N, Bitterman P B, Rennard S I, Cantin A, Crystal R G. Characterization of the lower respiratory tract inflammation of nonsmoking individuals was interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis 1987; 136: 1429–1434
  • Bégin R. Bronchoalveolar lavage in the pneumoconioses. Who needs it? Chest 1988; 94: 454, (Editorial)
  • International Labor Office/University of Cincinnati. International classification of radiographs of pneumoconiosis 1980, revised. Occupational safety and health series, International Labor Office, Geneva 1980, No. 22
  • Timbrell V, Gibson J C, Webster I. UICC reference samples of asbestos. Int J Cancer 1978; 3: 406–408
  • Killingsworth L M, Savory J. Manual nephelometric methods for immunochemical determination of immunoglobulins IgG, IgA and IgM in human serum. Clin Chem 1972; 18: 335–339
  • Walker W, Ulmer D D, Vallee B L. Metalloenzymes and myocardal infarction, II: malic and lactic dehydrogenase and zinc concentration in serum. N Engl J Med 1956; 255: 449–456
  • Turner-Warwick M, Haslam P L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135: 26–34
  • Snedecor G W, Cochran C W. Statistics Methods. Iowa State University Press, Ames 1967
  • Dixon W J. BMDP Statistical Software Manual. University of California Press, Los Angeles, CA 1985; 555–594
  • Wagner J C, Berry G, Skidmore J W, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974; 29: 252–269

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.